Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-10-260623
Filing Date
2010-11-15
Accepted
2010-11-15 16:05:06
Documents
4
Period of Report
2010-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 11803
2 PRESS RELEASE DATED NOVEMBER 15, 2010 dex991.htm EX-99.1 32567
3 PRESS RELEASE DATED NOVEMBER 15, 2010 REGARDING NASDAQ LISTING dex992.htm EX-99.2 10200
4 GRAPHIC g120757g84d99.jpg GRAPHIC 3307
  Complete submission text file 0001193125-10-260623.txt   60679
Mailing Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS CORP (Filer) CIK: 0001447028 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-34949 | Film No.: 101192377
SIC: 2834 Pharmaceutical Preparations